New PLA venture aims to kindle bioplastics industry in MENA region

Iranpolymer/Baspar SS Royal Kit Emirates Investment and Global Biopolymers Industries have partnered to form a new company called Emirates Biotech, headquartered in Dubai, in the United Arab Emirates. The initiative will focus on the production and marketing of PLA biopolymers across the Middle East, Africa, and India.
The partnership agreement was signed by Theodorus Everwijn on behalf of Global Biopolymers Industries, and by Shaikh Suhail Ali Saeed Rashed Al-Maktoum and Dr. Shadi Jabari, on behalf of SS Royal Kit Emirates Investment, and investment company in the MENA region with interests in a range of different sectors, including biotech.
Emirates Biotech, which has emerged from the former Gulf Biopolyers Industries, plans to build a PLA production facility in the United Arab Emirates. The facility will be located in Abu Dhabi’s KEZAD Free Zone
Commercial operations are due to start in early 2025; construction of the company’s first PLA production plant will commence before 2026. According to Theodorus Everwijn, PLA biopolymers are one of the ‘key innovations to lower society’s carbon footprint and combat global plastic pollution’.
Another notable figure in the bioplastics industry, François de Bie, formerly of Total Corbion PLA and a previous chairman of the European Bioplastics organisation, has also joined the Dubai-based venture.
sustainableplastics